mRNA |
TL-1-85 |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.02 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.02 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.02 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.02 |